Swedish biotechnology company Probi has appointed Peter Nählstedt as its new CEO.
Peter Nählstedt has extensive experience from the international life science industry through various executive positions involving strategy, marketing and sales at GE Healthcare Life Science, states the company in a press release. Peter Nählstedt joins Probi from Trelleborg Marine Systems where he has been responsible for operations in Europe, South America and North Africa.
“With the recruitment of Peter Nählstedt, we gain an individual with a solid strategic and international business background which, combined with Probi’s strong management team, will propel Probi into the next phase of its development in the form of continued expansion and further broadening of the operation, primarily in the international market,” said Per Lundin, Chairman of the Board of Probi.
Nählstedt will assume his new position on 7 January 2014. Gun-Britt Fransson, who has been Acting CEO since the end of May 2013, will continue in her role as Vice President Research and Development and member of Probi’s management group.
